Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Study of anti-inflammatory activity of FatsiphloginumTM (Fatsia japonica) and a new purified triterpene-rich extract of saponins (PS-551) in experimental model of arthritis

L. Tsiklauri, F. Drafi, S. Poništ, L. Slovák, M. Chrastina, K. Švík, Z. Kemoklidze, E. Kemertelidze, K. Bauerová

. 2019 ; 68 (Suppl 1) : S75-S85. [pub] 20191122
. 2019 ; () : S75-S85.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028160

In this study, two extracts from Fatsia japonica-FatsiphloginumTM (extract of triterpene glycosides containing 45-50 % of fatsiosides (FS)) and purified triterpene-rich extract of saponins with code name PS-551 (PS) were administered in combination with methotrexate (MTX) and in monotherapy to rats suffering adjuvant arthritis (AA). The anti-inflammatory activities of extracts were evaluated as monotherapies in comparison with untreated AA. PS administered in higher dose showed on day 28 effective decrease of hind paw volume (HPV), decreased activity of gamma-glutamyl transferase (GGT) in joints, and also interleukin-17A was decreased significantly on day 14. The higher dose of PS was more effective than both doses of FS. Further, we evaluated the higher doses of PS and FS in combination with MTX. PS improved the effect of MTX in combination more effective than FS (HPV, body weight and activity of GGT in joint). However, FS was more effective in reducing the level of IL-17A on day 14 and activity of GGT in spleen than PS. In conclusion, our study showed that generally FS has higher anti-arthritic activity comparing to PS. Thus, the novel combination of FatsiphloginumTM and methotrexate could be interesting for future clinical studies in patients suffering auto-immune diseases.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028160
003      
CZ-PrNML
005      
20220328133903.0
007      
ta
008      
211105s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934328 $2 doi
035    __
$a (PubMed)31755293
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Tsiklauri, L. $u Iovel Kutateladze Pharmacochemistry Institute, Tbilisi State Medical University, Tbilisi, Georgia
245    10
$a Study of anti-inflammatory activity of FatsiphloginumTM (Fatsia japonica) and a new purified triterpene-rich extract of saponins (PS-551) in experimental model of arthritis / $c L. Tsiklauri, F. Drafi, S. Poništ, L. Slovák, M. Chrastina, K. Švík, Z. Kemoklidze, E. Kemertelidze, K. Bauerová
504    __
$a Literatura
520    9_
$a In this study, two extracts from Fatsia japonica-FatsiphloginumTM (extract of triterpene glycosides containing 45-50 % of fatsiosides (FS)) and purified triterpene-rich extract of saponins with code name PS-551 (PS) were administered in combination with methotrexate (MTX) and in monotherapy to rats suffering adjuvant arthritis (AA). The anti-inflammatory activities of extracts were evaluated as monotherapies in comparison with untreated AA. PS administered in higher dose showed on day 28 effective decrease of hind paw volume (HPV), decreased activity of gamma-glutamyl transferase (GGT) in joints, and also interleukin-17A was decreased significantly on day 14. The higher dose of PS was more effective than both doses of FS. Further, we evaluated the higher doses of PS and FS in combination with MTX. PS improved the effect of MTX in combination more effective than FS (HPV, body weight and activity of GGT in joint). However, FS was more effective in reducing the level of IL-17A on day 14 and activity of GGT in spleen than PS. In conclusion, our study showed that generally FS has higher anti-arthritic activity comparing to PS. Thus, the novel combination of FatsiphloginumTM and methotrexate could be interesting for future clinical studies in patients suffering auto-immune diseases.
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika $x aplikace a dávkování $7 D000893
650    _2
$a aralkovité $x chemie $7 D027481
650    _2
$a artritida experimentální $x farmakoterapie $7 D001169
650    _2
$a interleukin-17 $x krev $7 D020381
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methotrexát $x aplikace a dávkování $7 D008727
650    _2
$a rostlinné extrakty $x terapeutické užití $7 D010936
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední LEW $7 D011917
650    _2
$a saponiny $x aplikace a dávkování $7 D012503
650    _2
$a triterpeny $x aplikace a dávkování $7 D014315
650    _2
$a gama-glutamyltransferasa $x metabolismus $7 D005723
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dráfi, František, $d 1984- $7 xx0267302 $u Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Poništ, Silvester $7 xx0096658 $u Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Slovák, Lukáš, $d 1988- $7 xx0267306 $u Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Chrastina, Martin $7 xx0126326 $u Jessenius Faculty of Medicine in Martin, Comenius University, Slovak Republic
700    1_
$a Švík, Karol $7 xx0119737 $u Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Kemoklidze, Z. $u Iovel Kutateladze Pharmacochemistry Institute, Tbilisi State Medical University, Tbilisi, Georgia
700    1_
$a Kemertelidze, E. $u Iovel Kutateladze Pharmacochemistry Institute, Tbilisi State Medical University, Tbilisi, Georgia
700    1_
$a Bauerová, Katarína, $d 1961- $7 xx0267301 $u Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, Suppl 1 (2019), s. S75-S85
773    0_
$t 69th Czech-Slovak pharmacological days $g (2019), s. S75-S85 $w MED00208902
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31755293 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20220328133901 $b ABA008
999    __
$a ok $b bmc $g 1728763 $s 1148705
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 68 $c Suppl 1 $d S75-S85 $e 20191122 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2019 $d S75-S85 $m 69th Czech-Slovak pharmacological days $x MED00208902
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace